| Dept. of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, USA |
|
| Dept. of Pharmaceutical Chemistry, School of Pharmacy, Univ. Milan, Italy |
|
| Institute of Internal and Vascular Medicine, School of Medicine, Univ. Perugia, Italy |
|
| Dept. of Biochemical Pharmacology, The William Harvey Research Institute, London, UK |
|
| Dept. of Experimental Pharmacology, School of Pharmacy, Univ. Naples, Italy |
|
| The Robert Gordon University, School of Pharmacy, Aberdeen, UK |
|
| 1 | Emanueli C, Van Linthout S, Salis MB, Monopoli A, Del Soldato P, Ongini E, Madeddu P. (2004) The nitric oxide-releasing aspirin derivative, NCX 4016, promotes separative angiogenesis and prevents apoptosis in a model of peripheral vascular disease. Artherioscler Tromb Vasc Biol; 24:2082-7. |
| 2 | Furlan R, Kurne A, Bergami A, Brambilla E, Maucci R, Gasparini L, Butti E, Comi G, Ongini E, Martino G. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis (2004) J Neuroimmunol. 150 : 10-9. |
| 3 | Gasparini L, Ongini E, Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s Disease: old and new mechanism of action. (2004) J Neurochem 91: 524-536. |
| 4 | Iwanaga Y, Gu Y, Mieterle T, Presotto C, Del Soldato P, Peterson KL, Ongini E, Condorelli G, Ross Jr J. A nitric oxide-releasing derivative of enalapril, NCX 899, prevents progressive cardiac dysfunction and remodeling in hamsters with heart failure. FASEB.J. : 587-588. |
| 5 | Ongini E, Impagnatiello I, Bonazzi A, Guzzetta M, Govoni M, Monopoli A, Del Soldato P, Ignarro LJ. Nitric oxide (NO)-releasing derivatives, a new class of drugs showing enhanced antiproliferative and anti-inflammatory properties. (2004) Proc Nat Acad Sci USA. 101:8497-8502. |
| 6 | Chiroli V, Benedini F, Ongini E, Del Soldato P. Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin.(2003) Eur J Med Chem. 38: 441-446. |
